Ipca Laboratories Ltd News
Nifty Pharma index hits 2-year low; Cipla, Divis, Laurus Labs at 52-wk lows
Analysts said the pace of US FDA inspections has again picked-up in the last few months post Covid, and they have seen increased incidents with 483 observations and adverse outcomes
 "Nifty Pharma index hits 2-year low; Cipla, Divis, Laurus Labs at 52-wk lows")
Updated On : 14 Mar 2023 | 2:27 PM IST
Ipca Labs slips 5%, hits 52-week low on weak December quarter results
In Q3, Ipca's operating profit margin was lowest since FY19, impacted by lower gross margins, and continued higher overheads.
 "Ipca Labs slips 5%, hits 52-week low on weak December quarter results")
Updated On : 17 Feb 2023 | 11:07 AM IST
